GAP-43

Biomarker

3 papers5 findings

  • Humans2
  • Animals1

Effects

1

Cognitive and functional decline

no changein humans1

1 study
  1. GAP-43 has no effect on cognitive and functional decline in humans (No significant association; p-values > 0.26).

    “GAP-43 was associated with faster decline in women ( p -values < 0.02) but not men ( p -values > 0.26).”

    HumansCommunity-dwelling older adults free of clinical dementia or strokecerebrospinal fluidMean 6.4-year follow-upmales

    Higher protein level linked to faster cognitive decline in women

    Alzheimer's research & therapy11 Oct 2026

Associations

4

Functional impairment

upin humans1

1 study
  1. GAP-43 is associated with functional impairment in humans (β = 0.002, p = 0.003).

    “and greater functional impairment (β = 0.002, p = 0.003).”

    HumansFree of clinical dementia or strokecerebrospinal fluidCross-sectional baselineboth; 31% femalesn = 161

    Higher protein level linked to faster cognitive decline in women

    Alzheimer's research & therapy11 Oct 2026

Visuospatial function

downin humans1

1 study
  1. GAP-43 is associated with visuospatial function in humans (β=-0.0004, p = 0.005).

    “higher GAP-43 was associated with worse language (β=-0.0005, p = 0.04) and visuospatial function (β=-0.0004, p = 0.005)”

    HumansFree of clinical dementia or strokecerebrospinal fluidCross-sectional baselineboth; 31% femalesn = 161

    Higher protein level linked to faster cognitive decline in women

    Alzheimer's research & therapy11 Oct 2026

Language performance

downin humans1

1 study
  1. GAP-43 is associated with language performance in humans (β=-0.0005, p = 0.04).

    “In cross-sectional analyses, higher GAP-43 was associated with worse language (β=-0.0005, p = 0.04)”

    HumansFree of clinical dementia or strokecerebrospinal fluidCross-sectional baselineboth; 31% femalesn = 161

    Higher protein level linked to faster cognitive decline in women

    Alzheimer's research & therapy11 Oct 2026

Cognitive and functional decline

upin humans1

1 study
  1. GAP-43 is associated with cognitive and functional decline in humans.

    “GAP-43 was associated with faster decline in women ( p -values < 0.02) but not men ( p -values > 0.26).”

    HumansCommunity-dwelling older adults free of clinical dementia or strokecerebrospinal fluidMean 6.4-year follow-upfemales

    Higher protein level linked to faster cognitive decline in women

    Alzheimer's research & therapy11 Oct 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 24 in 12 months